銘柄コードRNXT
会社名レノヴォRx
上場年月日2021/08/26
発行価格9.00
設立日2012
代表者Mr. Shaun R. Bagai
マーケットナスダック
従業員数8
証券種類普通株式
会計年度末12-31
所在地4546 El Camino Real,Suite B1
都市Los Altos
州California
国米国
郵便番号94022
電話番号1-650-284-4433
URLhttp://www.renovorx.com
紹介RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem. Co.'s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening thei
